Addressing Drop Adherence

Show Description +

I. Paul Singh, MD, describes the use of iStent Infinite (Glaukos) and Dextenza (dexamethasone ophthalmic insert 0.4 mg, Ocular Therapeutix) to help reduce the drop burden for this patient.

Financial disclosure: Consultant (Glaukos)

Posted: 1/02/2024

Addressing Drop Adherence

I. Paul Singh, MD, describes the use of iStent Infinite (Glaukos) and Dextenza (dexamethasone ophthalmic insert 0.4 mg, Ocular Therapeutix) to help reduce the drop burden for this patient.

Financial disclosure: Consultant (Glaukos)

Posted: 1/02/2024

Please log in to leave a comment.

More in Glaucoma

Progressing at Normal Pressures: A Case for the OPAP

John P. Berdahl, MD; Natalia Morales, MD; Tanner J. Ferguson, MD; and Justin Schweitzer, OD, FAAO

The Road Ahead in Glaucoma Treatment

Iqbal Ike K. Ahmed, MD, FRCSC; Arsham Sheybani, MD; and Jason Bacharach, MD

AquaLumen Technique

Rajen U. Desai, MD